By Admin 
Donald Trump Tariff News: On one hand, there is turmoil at the global level due to the tariff policy of US President Donald Trump. Meanwhile, Trump has withdrawn his decision of 100 percent tariff imposed on generic medicines. After this decision, Indian pharma companies have heaved a sigh of relief. Nearly half of the generic medicines supplied to America are exported from India. In such a situation, Indian companies will get a lot of benefit from it.
Besides, American citizens who are dependent on pharma companies of India and other countries for such medicines will also benefit from it. Due to 100 percent tariff, a huge jump in the prices of specific generic medicines was expected in the American market. According to information received in a report, India alone exports 47 percent of the generic medicines supplied to America.
Demand for Indian medicines in American market
The export rate of Indian medicines to America is increasing rapidly. Exports of Indian pharma companies to reach $30 billion in the financial year 2025. In which a growth of about 31 percent is being seen every year. The demand for Indian generic medicines has also increased in the American market. The direct effect of which is visible in the pharma export data. After this decision of Trump, it is expected that the business of generic medicines will grow faster. India is such a big producer of medicines that it is known as the pharmacy of the world.
Trump had announced 100 percent tariff
Recently, Trump had announced through social media that America will impose 100 percent tariff on certain medicines. If a company produces medicines in America, then this tariff rate will not apply to them. After which a decline in the shares of pharma companies was seen.
However, American citizens are largely dependent on Indian medicines. Many medicines like diabetes, blood pressure, cholesterol and antibiotics are exported from India in large quantities. On average, American citizens have to spend less for medicines sent from India. Therefore, demand for Indian medicines remains in the American market.
Also read: Now there will be abundance of jobs! India-UK trade deal will open new doors of employment